Webinar | TiO₂ alternatives for food, pharma, and personal care Register Here

MELLO

MELLO develops probiotic delivery technology to enhance the effective delivery of probiotics.
2019
2-10
Copenhagen, Hovedstaden, Denmark
BiopharmaBiotechnologynologyMedicalPre & ProbioticsTherapeutics

Investment Funding

Last Funding Stage

Convertible Note

Total Funding Amount

548.38K

Last Funding Date

16-03-2023

Lead Investors

BioInnovation Institute, BioInnovation Institute Venture House